Pharmaceutical companies in Europe are requesting the … triple the amount on both generic and branded drugs compared to … to discuss the tariffs. Recently, pharmaceutical companies called for modifications to European …

ET Intelligence Group: Pharma companies are expected to stand out … by stable performance in US generics segment. However, it may fall … -on-year, led by US generics portfolio including gRevlimid. "We …

… ’s collaborative push to register generics and biosimilars in key international … middle income countries. "Indian pharma companies are realising that in order … to overcoming challenges faced by pharmaceutical companies in regulatory processes. "We …

Generic drugmaker Lupin has received U.S. … eligible for 180 days of generic drug exclusivity. The product will … product is bioequivalent to Otsuka Pharmaceutical Company’s Jynarque Tablets 15 mg …

… US health regulator for its generic version of Tolvaptan tablets indicated … the same strengths of Otsuka Pharmaceutical Company Ltd, it added. "Lupin … eligible for 180 days of generic drug exclusivity. This product will …

… leaned heavily toward branded drugmakers, generic medicines and the companies … to the already fragile generics ecosystem could trigger … , when it comes to generic drugmakers, “I don’t know … target both finished generic and non-generic products, plus medical …

… R&D investments by pharmaceutical companies to develop novel drug … these regulations is mandatory for pharmaceutical companies, prompting continuous improvement and rigorous … Drug Delivery Rising Demand for Generic Drugs Strengthens Business Case for …

… unprofitable as a result. Generic medicines, which are … executive of the British Generic Manufacturers Association, said the … Indian pharma companies,” B Partha Saradhi Reddy, chair of generic company … often include provisions that drugmakers who fail to supply …

On April 15, 2025, President Trump issued an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The order reaffirms and seeks to expand on policy initiatives introduced during the president’s first administration, with the …

… state began selling its own generic version of Narcan last year … produced by the Maryland-based pharmaceutical company Emergent BioSolutions. California is also …